Table 1 Detailed clinical information for the participants of discover cohort
ID | Age | Sex | Disease | Hypertension | Diabetes | Coronary heart disease | Smoke | Alcohol | Clinical presentation | Duration (mounth) | Suzuki stge | Subtype of MMD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 44 | M | MMD | N | N | N | N | N | ICH | 9 | 3 | Bilateral |
2 | 32 | M | MMD | Y | Y | N | N | Y | ICH | 5 | 4 | Bilateral |
3 | 47 | M | MMD | Y | Y | N | Y | Y | TIA | 8 | 4 | Bilateral |
4 | 46 | M | MMD | Y | N | N | N | N | TIA | 3 | 3 | Bilateral |
5 | 51 | F | MMD | Y | N | N | N | N | TIA | 36 | 3 | Bilateral |
6 | 35 | F | MMD | N | N | N | N | N | ICH | 5 | 4 | Bilateral |
7 | 36 | F | MMD | N | N | N | Y | N | TIA | 0.5 | 4 | Bilateral |
8 | 52 | M | MMD | Y | N | N | N | Y | TIA | 3 | 4 | Bilateral |
9 | 52 | M | MMD | N | N | N | N | N | TIA | 6 | 3 | Bilateral |
10 | 31 | F | MMD | N | N | N | N | N | TIA | 4 | 3 | Bilateral |
11 | 26 | M | EP | Y | N | N | N | N | EP | NA | NA | NA |
12 | 51 | M | EP | N | N | N | Y | Y | EP | NA | NA | NA |
13 | 30 | F | EP | N | N | N | N | N | EP | NA | NA | NA |